Toronto Dominion Bank’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7
Closed -$1.11K 2274
2025
Q4
$1.11K Buy
+7
New +$961 ﹤0.01% 1930

Other funds holding LABU

Toronto Dominion Bank's LABU Position: Q1 2026 in Review

Toronto Dominion Bank sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q1 2026, closing a stake of 7 shares — an estimated $1.11K sold.

Toronto Dominion Bank first reported a position in LABU in Q4 2025 and held it in 1 quarter. The position peaked at $1.11K in Q4 2025. 33 funds tracked by Wall St. Rank hold LABU as of Q1 2026.

  • Toronto Dominion Bank reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q1 2026 after selling out during the quarter.
  • Toronto Dominion Bank sold 7 Direxion Daily S&P Biotech Bull 3X ETF shares in Q1 2026, an estimated $1.11K.
  • Toronto Dominion Bank first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2025 and held it in 1 quarter.
  • Toronto Dominion Bank's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $1.11K in Q4 2025.
  • 33 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.